Links to the late-breaking studies at Heart Rhythm 2022
Here is a list with links for all of the late-breaking studies presented at the Heart Rhythm Society (HRS) 2022 Heart Rhythm conference April 28 to May 1 in San Francisco:
HRS Late-Breaking Clinical Trials 1: Updates and Registries
• Effect Of Intensive Versus Standard Blood Pressure Treatment On Incident Left-Ventricular Conduction Disease. Presented by Gregory Marcus.
• Clinical And Economic Impact Of An Organized Treatment Pathway On Atrial Fibrillation Patient From The Emergency Room To Electrophysiology Service (ER2EP Study). Presented by Dhanunjaya Lakkireddy.
• Clinical Outcomes Of Conduction System Pacing Compared To Biventricular Pacing In Patients Requiring Cardiac Resynchronization Therapy. Presented by Jiangang Zou.
• Early Rhythm Control In Patients With Atrial Fibrillation According To CHA2DS2-VASc Score And Age. Subgroup analysis of the EAST-AFNET 4 trial. Presented by Andreas Rillig.
HRS Late Breaking Clinical Trials 2: Clinical Innovations
• Feasibility and Safety of Catheter-Based Cardioneural Ablation: Results From the Multicenter US CNA Registry. Presented by Roderick Tung.
• Etripamil Nasal Spray Is Effective And Safe For Conversion Of Repeated Spontaneous Episodes Of Paroxysmal Supraventricular Tachycardia During Long-term Follow-up: Results From The Node-302 Study. Presented by James Ip.
• Sex Hormones And Repolarization Dynamics During The Menstrual Cycle In Women With Congenital And Drug-Induced Long QT Syndrome. Presented by Ilan Goldenberg.
• Rescue Left Bundle Branch Area Pacing For Coronary Sinus Lead Failure Or Non-response To BIV-CRT: Results From International LBBAP Collaborative Study Group. Presented by Pugazhendhi Vijayaraman.
HRS Late Breaking Clinical Trials 3: Randomized Clinical Trials
• Subcutaneous Versus Transvenous Defibrillators: The Atlas Trial. Presented by Healey, Jeffrey.
• Left Bundle Branch Pacing Versus Biventricular Pacing In Cardiac Resynchronization Therapy: A Randomized Controlled Pilot Trial. Presented by Jiangang Zou.
• Epicardial Ablation In Brugada Syndrome To Prevent Sudden Death: Results From A Randomized Clinical Trial. Presented by Giuseppe Ciconte.
• App-based Mental Training To Reduce Atrial Fibrillation Related Symptoms – The MENTAL AF Randomized Controlled Trial. Presented by Julia A. Lurz.
HRS Late Breaking Clinical Trials Session 4: Late Breaking Science
• High Power Versus Standard Power Radiofrequency Ablation For Pulmonary Vein Isolation: The Short-AF Study. Presented by Adam Lee.
• In-hospital Outcomes For Next-generation Watchman FLX Compared With Watchman Generation 2.5. Presented by James V. Freeman.
• Cardiac AAV:PKP2 Gene Therapy Reduces Ventricular Arrhythmias, Reverses Adverse Right Ventricular Remodeling, Improves Heart Function, and Extends Survival in a Pkp2-deficient Mouse Model of Arrhythmogenic Right Ventricular Cardiomyopathy. Presented by Zhihong Jane Yang.
• Artificial Intelligence To Identify Left Ventricular Dysfunction From An Apple Watch ECG: A Prospective, Decentralized International Pragmatic Study by Mayo Clinic. Presented by Zachi Itzhak Attia.
Related Heart Rhythm Conference Content:
Same-day discharge for AFib ablation a success thanks to telehealth
High power vs. standard RF ablation leads to better pulmonary vein isolation and shorter procedures
STROKE AF study shows insertable cardiac monitors detect 4 times more AFib than Holter monitoring
Dave Fornell has covered healthcare for more than 17 years, with a focus in cardiology and radiology. Fornell is a 5-time winner of a Jesse H. Neal Award, the most prestigious editorial honors in the field of specialized journalism. The wins included best technical content, best use of social media and best COVID-19 coverage. Fornell was also a three-time Neal finalist for best range of work by a single author. He produces more than 100 editorial videos each year, most of them interviews with key opinion leaders in medicine. He also writes technical articles, covers key trends, conducts video hospital site visits, and is very involved with social media. E-mail: dfornell@innovatehealthcare.com